TermDefinition
Balanced translocationRearrangement of genetic material equally between chromosomes
Cell-free fetal DNAFetal DNA freely circulating in maternal blood; measured as part of aneuploidy screening for high-risk women
Combined testFirst trimester measurement of hormones (beta subunit of human chorionic gonadotropin and pregnancy-associated plasma protein A) plus nuchal translucency
Fully integrated testCombined test in first trimester plus quadruple screen in second trimester; screening report produced after both complete
Genetic mosaicismPresence of more than one population of cells with different genotypes in a single individual
Nuchal translucencyFluid-filled nuchal space (posterior neck) best visualized on ultrasonography between 11 and 14 weeks of gestation
Sequential contingent testAfter initial screening report in first trimester, women at high risk are offered invasive diagnostic testing; women at moderate risk are offered further second trimester testing; and women at low risk have no further testing
Unbalanced translocationInheritance of a chromosome with extra or missing genetic material from a parent with a balanced translocation